Respiratory Disease Testing Market, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

The respiratory system is divided into two parts; upper respiratory tract and lower respiratory tract. The upper respiratory tract includes pharynx, larynx and nasal passages, while the lower respiratory tract includes trachea, lungs and bronchi. Respiratory Disease Testing is carried out for diagnosis of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and pneumonia. Increasing product approvals, increasing prevalence of respiratory disorders in developed and developing economies along with increasing technological advancements in product development.

Key features of the study:

This report provides in-depth analysis of the Global Respiratory Disease Testing market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Respiratory Disease Testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., Philips Healthcare, and Quest Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Respiratory Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Respiratory Disease Testing market

Detailed Segmentation:

Global Respiratory Disease Testing Market, By Test Type:
- Imaging Test
- Spirometry
- Peak Flow Test
- Blood Gas Test
- Lung Volume Test
- Others
Global Respiratory Disease Testing Market, By End User:
- Hospitals
- Physician Offices
- Clinical Laboratories
Global Respiratory Disease Testing Market, By Region:
- North America
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - U.K.
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - By Test Type:
  - Imaging Test
  - Spirometry
  - Peak Flow Test
  - Blood Gas Test
  - Lung Volume Test
  - Others
  - By End User
  - Hospitals
  - Physician Offices
  - Clinical Laboratories
  - By Country
  - North Africa
  - Central Africa
  - South Africa
Company Profiles
- CareFusion Corporation *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Carestream Health, Inc.
- COSMED
- Futuremed America, Inc.
- GE Healthcare
- MGC Diagnostics Corporation
- ndd Medical Technologies, Inc.
- Nihon Kohden Corporation
- Perkin Elmer, Inc.
- Philips Healthcare
- Quest Diagnostics
"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4030

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Country
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
Impact of COVID19 on market

4. Global Respiratory Disease Testing Market, By Test Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Spirometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Peak Flow Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Blood Gas Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Lung Volume Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Respiratory Disease Testing Market, By End User, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Physician Offices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Respiratory Disease Testing Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles
- CareFusion Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Carestream Health, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- COSMED
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Futuremed America, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- MGC Diagnostics Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ndd Medical Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nihon Kohden Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PerkinElmer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Philips Healthcare
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Quest Diagnostics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

8. Section

References
Research Methodology
About us and Sales Contact

Respiratory Disease Testing Market, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028